This inventor holds 20 USPTO granted patents and 1 EPO patent, primarily in Microbial Biotechnology. Top assignees: Kyowa Hakko Kogyo Co., Ltd., Nisshin Flour Milling Co., Ltd., Taisho Pharmaceutical Co., Ltd.. Active years: 1980-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ueno, JP (1980)
- Uenomachi, JP (1981)
- Hachioji, JP (1982 - 2007)
- Tokyo, JP (1987 - 2008)
- Toyko, JP (2009)
Company Filing History:
5 out of 730 
4 out of 200 
4 out of 314 
Years Active: 1980-2009
Areas of Expertise:
Title: A Closer Look at Inventor Haruo Seto
Introduction: Haruo Seto, a prolific inventor based in Tokyo, JP, has made significant contributions to the field of isoprenoid compounds with an impressive portfolio of 20 patents. His groundbreaking work has focused on processes for producing isoprenoid compounds by microorganisms and methods for screening compounds with antibiotic or weeding activity.
Latest Patents: Seto's latest patents involve a revolutionary process for producing isoprenoid compounds using DNA encoding proteins to enhance efficiency in biosynthesis. These compounds have shown promise in pharmaceuticals for cardiac diseases, osteoporosis, cancer prevention, immunopotentiation, health foods, and anti-fouling paint products against barnacles. The method for screening substances with antibiotic and weeding activities is a testament to Seto's innovative approach in the industry.
Career Highlights: Seto's expertise has been honed through his tenure at esteemed companies such as Kyowa Hakko Kogyo Co., Ltd. and Taisho Pharmaceutical Co., Ltd. These experiences have shaped him into a visionary inventor at the forefront of isoprenoid research and development.
Collaborations: Throughout his career, Seto has collaborated closely with notable peers in the field, including Noboru Otake and Kazuo Shin-Ya. These collaborations have fostered a dynamic environment for sharing ideas and pushing the boundaries of scientific discovery.
Conclusion: Haruo Seto's dedication to advancing the field of isoprenoid compounds through innovative patent applications reflects his commitment to driving forward progress in the pharmaceutical and biotechnology sectors. His pioneering work continues to inspire future generations of inventors and researchers in the pursuit of groundbreaking solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile